You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
ULTRASONIC NONDESTRUCTIVE TECHNIQUES AND INSTRUMENTATION FORTRANSPARENT ENCLOSURES OF HIGH PERFORM A/C
SBC: AMERICAN PHOTONICS TECHNOLOGY, INC. Topic: N/AAIRCRAFT TRANSPARENCIES REPRESENT ONE OF THE MOST SIGNIFICANT LIFE CYCLE COST TO THE U.S. AIR FORCE. THE MAJOR CAUSE FOR THE OPTICAL IMPAIRMENT IS THE DEGRADATION IN PLASTICS KNOWN AS CRAZING WHICH OCCURS DUE TO SURFACE STRESSES AND IS ACCELERATED BY THE ENVIRONMENTALFACTORS. THE OBJECTIVE OF THE PROJECT IS TO DEVELOP THE NECESSARY TECHNIQUE TO MEASURE AND QUANTIFY THE CRAZING AND SHOW FEASIBILITY ...
SBIR Phase II 1991 Department of DefenseAir Force -
DEVELOPMENT OF AN ECONOMICALLY COMPETITIVE OYSTER/SHRIMP PRODUCTION SYSTEM
SBC: Aquaculture Technology Topic: N/ATHE RESEARCH WILL PROVIDE TECHNICAL INFORMATION ON THE PRODUCTION OF PREMIUM QUALITY HALF-SHELL OYSTERS USING SHRIMP POND EFFLUENT. SHRIMP POND WATER IS PUMPED THROUGH FLUIDIZED OYSTER COLUMNS, PASSED THOUGH SEDIMENTATION TANKS,AND RETURNED TO THE POND. WHEN FED TO OYSTERS, THE ALGAE- LADEN POND WATER CAN PRODUCE MARKET-SIZE OYSTERS IN LESS THAN 200 DAYS. IN THE FLUIDIZED COLUMNS, THE OYSTERS ARE ...
SBIR Phase II 1991 Department of Agriculture -
PENETRATING SEALANTS
SBC: Beckus Corp Inc Topic: N/ABECKUS CORP INC PROPOSES TO RESEARCH AND DEVELOP PRODUCTS WHICH WILL REVOLUTIONIZE THE STATE OF THE ART IN CONCRETE SEALANTS. MUCH OF THE PROPOSED RESEARCH HAS ALREADY BEEN ACHIEVED IN THE COURSE OF DEVELOPING OTHER BECKUS PRODUCTS. BECKUS HAS DEVELOPED AND PATENTED THE ONLY KNOWN CURE FOR MASONRY EFFLORESCENCE. IN THE COURSE OF THIS AND MANY OTHER DISCOVERIES BECKUS HAS ACQUIRED THE SKILL AND TEC ...
SBIR Phase I 1991 Department of DefenseArmy -
DEVELOPING MATERIALS TO ENHANCE TRIBAL ACCESS TO INVESTMENT FINANCING RESOURCES
SBC: Charles Trimble Co Topic: N/ATHIS PHASE I PROJECT WILL RESEARCH THE PROBLEMS THAT TRIBES ENCOUNTER IN THEIR EFFORTS TO SECURE FINANCING FROM INVESTMENT BANKS AND OTHER PRIVATE SECTOR FINANCIAL RESOURCES AND CONSIDER MEASURES TRIBES MIGHT TAKE TO REMEDY THOSE PROBLEMS. IN ADDITION, THIS PHASE I EFFORT WILL RESEARCH AND IDENTIFY PRIVATE SECTOR FINANCIAL RESOURCES TRIBES MIGHT DRAW UPON FOR THEIR DEVELOPMENT NEEDS, THE PERCEPTIO ...
SBIR Phase II 1991 Department of Health and Human Services -
PRODUCTION OF DENQUE 2 ENVELOP PROTEIN IN THE YEAST SACCHAROMYCES CEREVISIAE
SBC: HAWAII BIOTECH, INC. Topic: N/ATHE FOUR SEROTYPES OF DENGUE VIRUSES ARE A LEADING CAUSE OF MORBIDITY THROUGHOUT THE TROPICS AND SUBTROPICS. FOR USE IN DIAGNOSTICS AND IN SUBUNIT VACCINES AGAINST DENGUE, A RELIABLE AND INEXPENSIVE SOURCE OF DENGUE ANTIGENS IS REQUIRED. FOR THESE PURPOSES, EXPRESSION OF RECOMBINANT ANTIGENS IN MICROORGANISMS IS BEST SUITED. WE PROPOSE TO USE THE YEAST SACCHAROMYCES CEREVISIAE TO PRODUCE THE DENGU ...
SBIR Phase II 1991 Department of DefenseArmy -
IMMUNOASSAYS FOR TAXOL
SBC: HAWAII BIOTECH, INC. Topic: N/ATAXOL IS A PROMISING NEW ANTICANCER DRUG, ISOLATED FROM THE BARK OF THE WESTERN YEW (TAXUS BREVEFOLIA), AND IS CURRENTLYIN PHASE II CLINICAL TRIALS. DEVELOPMENT OF THIS DRUG IS IMPEDED BY A SUPPLY SHORTAGE. IDENTIFICATION OF NEW TAXOL SOURCES IS HAMPERED BY THE LACK OF SUITABLE ASSAYS FOR DETECTING TAXOL AND TAXANES IN BIOLOGICAL MATRICES. IN PHASE I OF THIS PROJECT, POLYCLONAL ANTISERA WERE RAISE ...
SBIR Phase II 1991 Department of Health and Human Services -
BISPECIFIC ANTIBODY FOR DIRECTED DELIVERY OF PALYTOXIN
SBC: HAWAII BIOTECH, INC. Topic: N/ACONSIDERABLE INTEREST HAS BEEN FOCUSSED ON THE PRODUCTION AND CHARACTERIZATION OF THERAPEUTIC IMMUNOCONJUGATES. SUCH HYBRID MOLECULES USUALLY CONSIST OF A MONOCLONAL ANTIBODY WITH COVALENTLY ATTACHED TOXIN, DRUG, OR RADIOISOTOPE. SOME OF THESE AGENTS HAVE BEEN SHOWN TO BE CLINICALLY USEFUL FOR IMMUNOSUPPRESSION OR CANCER TREATMENT. HOWEVER, THESE COVALENTLY LINKED IMMUNOCONJUGATES ALSO SUFFER FROM ...
SBIR Phase I 1991 Department of Health and Human Services -
COFFEE ALPHA-GALACTOSIDASE CDNA CLONING FOR BLOOD PROCESSING
SBC: HAWAII BIOTECH, INC. Topic: N/AIT HAS BEEN DEMONSTRATED THAT ALPHA-GALACTOSIDASE AND ALPHA-N-ACETYL GALACTOSAMINIDASE HAVE THE ABILITY TO ENZYMATICALLY CONVERT TYPE B AND A HUMAN ERYTHROCYTES, RESPECTIVELY, TO SEROTYPICALLY TYPE O ERYTHROCYTES. THIS ABILITY WOULD OBVIATE THE NEED FOR TYPING OR CROSSMATCHING, WOULD SIMPLIFY INVENTORY IN BLOOD BANKS, AND WOULD EXPEDITE THE DELIVERY OF TRANSFUSIONS. WE WILL SYNTHESIZE AND CLONE TH ...
SBIR Phase I 1991 Department of Health and Human Services -
UREASE-LINED IMMUNOASSAY REAGENT STABILITY STUDIES
SBC: HAWAII BIOTECH, INC. Topic: N/AN/A
SBIR Phase I 1991 Department of DefenseArmy -
MINIATURIZED FT-IR SENSOR FOR INFRARED MEASUREMENTS
SBC: HAWAII BIOTECH, INC. Topic: N/AN/A
SBIR Phase I 1991 Department of DefenseNavy